Geode Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Buy |
|
|||||
|
2025
Q1 | $42.7M | Buy |
|
|||||
|
2024
Q4 | $58.7M | Buy |
|
|||||
|
2024
Q3 | $52.2M | Buy |
|
|||||
|
2024
Q2 | $68.6M | Buy |
|
|||||
|
2024
Q1 | $99.4M | Buy |
|
|||||
|
2023
Q4 | $97.6M | Buy |
|
|||||
|
2023
Q3 | $59.2M | Buy |
|
|||||
|
2023
Q2 | $137M | Sell |
|
|||||
|
2023
Q1 | $121M | Buy |
|
|||||
|
2022
Q4 | $90.5M | Buy |
|
|||||
|
2022
Q3 | $116M | Buy |
|
|||||
|
2022
Q2 | $72.8M | Buy |
|
|||||
|
2022
Q1 | $75.9M | Buy |
|
|||||
|
2021
Q4 | $64M | Buy |
|
|||||
|
2021
Q3 | $39.2M | Buy |
|
|||||
|
2021
Q2 | $70.7M | Buy |
|
|||||
|
2021
Q1 | $44.9M | Buy |
|
|||||
|
2020
Q4 | $53.6M | Buy |
|
|||||
|
2020
Q3 | $26.5M | Buy |
|
|||||
|
2020
Q2 | $28.3M | Buy |
|
|||||
|
2020
Q1 | $22.2M | Buy |
|
|||||
|
2019
Q4 | $20.1M | Buy |
|
|||||
|
2019
Q3 | $15.1M | Buy |
|
|||||
|
2019
Q2 | $14.6M | Buy |
|
|||||
|
2019
Q1 | $9.5M | Buy |
|
|||||
|
2018
Q4 | $5.56M | Buy |
|
|||||
|
2018
Q3 | $6.64M | Buy |
|
|||||
|
2018
Q2 | $7.92M | Buy |
|
|||||
|
2018
Q1 | $3.32M | Buy |
|
|||||
|
2017
Q4 | $3.17M | Buy |
|